These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36791577)

  • 1. The pan-cancer landscape of abnormal DNA methylation and intratumor microorganisms.
    Zhou P; Lu SL; Chang L; Liao B; Cheng M; Xu X; Sui X; Liu F; Zhang M; Wang Y; Yang R; Li R; Pan H; Zhang C
    Neoplasia; 2023 Mar; 37():100882. PubMed ID: 36791577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratumor heterogeneity of breast cancer detected by epialleles shows association with hypoxic microenvironment.
    Wang Y; Zhang Y; Huang Y; Chen C; Zhang X; Xing Y; Gu Y; Zhang M; Cai L; Xu S; Sun B
    Theranostics; 2021; 11(9):4403-4420. PubMed ID: 33754068
    [No Abstract]   [Full Text] [Related]  

  • 3. A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy.
    Xu B; Lu M; Yan L; Ge M; Ren Y; Wang R; Shu Y; Hou L; Guo H
    Front Immunol; 2021; 12():796647. PubMed ID: 34956232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigation of lipid metabolism dysregulation and the effects on immune microenvironments in pan-cancer using multiple omics data.
    Hao Y; Li D; Xu Y; Ouyang J; Wang Y; Zhang Y; Li B; Xie L; Qin G
    BMC Bioinformatics; 2019 May; 20(Suppl 7):195. PubMed ID: 31074374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pan-cancer analysis of driver gene mutations, DNA methylation and gene expressions reveals that chromatin remodeling is a major mechanism inducing global changes in cancer epigenomes.
    Youn A; Kim KI; Rabadan R; Tycko B; Shen Y; Wang S
    BMC Med Genomics; 2018 Nov; 11(1):98. PubMed ID: 30400878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Methylation Immune Subtypes and Establishment of a Prognostic Signature for Gliomas Using Immune-Related Genes.
    Hu Z; Zhang H; Fan F; Wang Z; Xu J; Huang Y; Dai Z; Cao H; Zhang X; Liu Z; Cheng Q
    Front Immunol; 2021; 12():737650. PubMed ID: 34804019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pan-Cancer Analysis of PDIA3: Identifying It as a Potential Biomarker for Tumor Prognosis and Immunotherapy.
    Zhang J; Wang K; Hainisayimu T; Li H
    Oxid Med Cell Longev; 2022; 2022():9614819. PubMed ID: 36046686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pediatric Pan-Central Nervous System Tumor Methylome Analyses Reveal Immune-Related LncRNAs.
    Li Y; Xu S; Xu D; Pan T; Guo J; Gu S; Lin Q; Li X; Li K; Xiang W
    Front Immunol; 2022; 13():853904. PubMed ID: 35603200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pan-cancer analysis of AIM2 inflammasomes with potential implications for immunotherapy in human cancer: A bulk omics research and single cell sequencing validation.
    Qin Y; Pan L; Qin T; Ruan H; Zhang Y; Zhang Y; Li J; Yang J; Li W
    Front Immunol; 2022; 13():998266. PubMed ID: 36248785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Pan-Cancer Landscape of Crosstalk Between TRP Family and Tumour Microenvironment Relevant to Prognosis and Immunotherapy Response.
    Wu G; He M; Yin X; Wang W; Zhou J; Ren K; Chen X; Xue Q
    Front Immunol; 2022; 13():837665. PubMed ID: 35493463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
    Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
    BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pan-cancer analysis of the DNA methylation patterns of long non-coding RNA.
    Wang S; Wang R; Gao F; Huang J; Zhao X; Li D
    Genomics; 2022 Jul; 114(4):110377. PubMed ID: 35513292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor DNA methylation profiles correlate with response to anti-PD-1 immune checkpoint inhibitor monotherapy in sarcoma patients.
    Starzer AM; Berghoff AS; Hamacher R; Tomasich E; Feldmann K; Hatziioannou T; Traint S; Lamm W; Noebauer-Huhmann IM; Furtner J; Müllauer L; Amann G; Bauer S; Schildhaus HU; Preusser M; Heller G; Brodowicz T
    J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33762319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.
    Zou R; Jiang Q; Jin T; Chen M; Yao L; Ding H
    Front Immunol; 2022; 13():956224. PubMed ID: 36032075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IMPDH1, a prognostic biomarker and immunotherapy target that correlates with tumor immune microenvironment in pan-cancer and hepatocellular carcinoma.
    Liu C; Zhang W; Zhou X; Liu L
    Front Immunol; 2022; 13():983490. PubMed ID: 36618420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
    Ding W; Chen G; Shi T
    Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation in the tumor microenvironment.
    Zhang MW; Fujiwara K; Che X; Zheng S; Zheng L
    J Zhejiang Univ Sci B; 2017 May; 18(5):365-372. PubMed ID: 28471108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancer.
    Lawrence MG; Pidsley R; Niranjan B; Papargiris M; Pereira BA; Richards M; Teng L; Norden S; Ryan A; Frydenberg M; Stirzaker C; Taylor RA; Risbridger GP; Clark SJ
    Clin Epigenetics; 2020 Mar; 12(1):48. PubMed ID: 32188493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pan-Cancer Multi-Omics Landscape of FOXO Family Relevant to Clinical Outcome and Drug Resistance.
    Xie J; Zhang J; Tian W; Zou Y; Tang Y; Zheng S; Wong CW; Deng X; Wu S; Chen J; Mo Y; Xie X
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-omics analysis revealed the regulation mode of intratumor microorganisms and microbial signatures in gastrointestinal cancer.
    Wang S; Liu P; Yu J; Liu T
    Carcinogenesis; 2024 Mar; 45(3):149-162. PubMed ID: 37944024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.